CIK: 0000882095 · Show all filings
Period: Q4 2024 (Next →)
Filing Date: Feb 13, 2025
Total Value ($000): $1,551,148 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 6,720,803 | $515,418 | 33.2% | $86.39 | 0.0% | COMMON STOCK | 03940C100 |
| GLPG | GALAPAGOS NV | 16,707,477 | $461,727 | 29.8% | $27.64 | — | SPON ADR | 36315X101 |
| RCUS | ARCUS BIOSCIENCES INC | 30,061,124 | $447,610 | 28.9% | $16.33 | 0.0% | COM | 03969F109 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 2,209,471 | $34,865 | 2.2% | $16.10 | 0.0% | COM NEW | 045396207 |
| — | MERUS N V | 452,527 | $19,029 | 1.2% | $42.05 | — | COM | N5749R100 |
| KYTX | KYVERNA THERAPEUTICS INC | 4,126,119 | $15,432 | 1.0% | $4.79 | 0.0% | COM | 501976104 |
| CYPH | LEAP THERAPEUTICS INC | 5,319,148 | $15,293 | 1.0% | $2.97 | 0.0% | COM NEW | 52187K200 |
| TNGX | TANGO THERAPEUTICS INC | 4,854,443 | $15,000 | 1.0% | $4.64 | 0.0% | COM | 87583X109 |
| XLO | XILIO THERAPEUTICS INC | 9,105,451 | $8,696 | 0.6% | $0.98 | 0.0% | COM | 98422T100 |
| — | ALLOVIR INC | 16,635,286 | $6,987 | 0.5% | $0.42 | — | COM | 019818103 |
| HOOK | HOOKIPA PHARMA INC | 1,875,945 | $3,771 | 0.2% | $3.09 | 0.0% | COM NEW | 43906K209 |
| — | IKENA ONCOLOGY INC | 2,008,338 | $3,294 | 0.2% | $1.64 | — | COM | 45175G108 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,156,689 | $2,464 | 0.2% | $2.47 | 0.0% | COM | 019770106 |
| BRNS | BARINTHUS BIOTHERAPEUTICS PL | 620,351 | $749 | 0.0% | $1.21 | — | ADS | 91864C107 |
| AGEN | AGENUS INC | 231,663 | $635 | 0.0% | $3.70 | 0.0% | COM NEW | 00847G804 |
| — | KRONOS BIO INC | 188,567 | $179 | 0.0% | $0.95 | — | COM | 50107A104 |